Live Breaking News & Updates on Rahul darda

Stay informed with the latest breaking news from Rahul darda on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Rahul darda and stay connected to the pulse of your community

Brinton Pharmaceuticals ramps production of anti-Covid drug

Brinton Pharmaceuticals ramps production of anti-Covid drug
By
IANS
|
3 Views

US coronavirus death toll mounts to 6, Trump wants vaccine at âmaximum speedâ.. Image Source: IANS News
New Delhi, May 12 : Brinton Pharmaceuticals has more than tripled up the production of Faviton (Favipiravir 400) tablet, used as an oral antiviral therapy to treat mild to moderate symptoms of Covid-19 infection, the company said on Wednesday.
The brand received approval from Drugs Controller General of India (DCGI), in August last year, for the launch of Favipiravir 400mg under the brand name Faviton.
Brinton will increase production from 15 lac to 50 lac quantity, and will further continue to increase the production of its crucial medicines to help save lives. Faviton 400 mg is available in a strip of 10 tablets for Rs 790.

India , New-delhi , Delhi , Faviton-favipiravir , Brinton-pharmaceuticals , Drugs-controller-general , Rahul-darda , இந்தியா , புதியது-டெல்ஹி , டெல்ஹி , பிரிண்டன்-மருந்துகள் , மருந்துகள்-கட்டுப்படுத்தி-ஜநரல்

India's pharma sector needs a shot in the arm to fight the pandemic

SHARE
As India grapples with a massive second wave of coronavirus infections, the country’s pharmaceutical industry is under pressure to deliver vaccines and medicines.
Dubbed the ‘pharmacy of the world’, India’s sprawling pharmaceutical factories were expected to supply the bulk of Covid-19 vaccines and medicines to the world. But a record jump in coronavirus cases in a country of more than 1.3 billion people is putting the sector under strain. India’s health ministry on Saturday reported another 346,786 new Covid-19 infections.
“The pharmaceutical industry does need to ramp up its infrastructure to facilitate higher production of essential [drugs and vaccines],” says Dr Nikhil Mathur, the chief of medical services at Care Group of Hospitals.

Japan , India , Pune , Maharashtra , Albania , China , Bangalore , Karnataka , Delhi , Syria , Bharat , Astrazeneca-oxford-covid